Skip to main content

Maria Luisa Aznar Ruiz de Alegria

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Maria Luisa Aznar Ruiz de Alegria

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Projects

Malalties infeccioses

IP: Vicenç Falcó Ferrer
Collaborators: Jose Santos Santiago, Maria Luisa Aznar Ruiz de Alegria, Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Oscar Len Abad, Mª Carmen Ferrer Barberà, Javier Gomis Rodriguez, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juan Espinosa Pereiro, Bibiana Planas Ribas, Ma Dolores Rodríguez Pardo, Pau Bosch Nicolau, David Perea Pérez, Israel Molina Romero, Patricia Álvarez López, Vicente Descalzo Jorro, Marta Sanchiz Cruz, Nuria Serre Delcor, Julia Sellares Nadal, Fernando M Salvador Velez, Isabel Ruiz Camps, Jordi Gómez i Prat, María José Buzón Gómez, Hakima Ouaarab Essadek, Paula Suanzes Diez, Jordi Navarro Mercadé, Esperanza Esteban Serna, Raisa Morales Martinez, Joaquin Burgos Cibrian, Nerea Sanchez Gaona, Joan Rey Cano, Adrián Sánchez Montalvá, Cristina Mancebo Perez, Montserrat Llinás Vidal, Maider Arando Lasagabaster, Ibai Los Arcos Bertiz, Claudia Broto Cortes, Meritxell Genesca Ferrer, Ines Mercedes Oliveira Souto, Silvina Andrea Magnani
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00764
Duration: 01/01/2022 - 30/06/2025

Enfermedades infecciosas

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Eva Baldrich Rubio, Diana Pou Ciruelo, Begoña Treviño Maruri, Pau Bosch Nicolau, Nuria Serre Delcor, Fernando M Salvador Velez, Mª Teresa Tórtola Fernández, Adrián Sánchez Montalvá, Elena Sulleiro Igual, Ines Mercedes Oliveira Souto
Funding agency: Instituto de Salud Carlos III
Funding: 141000
Reference: CB21/13/00029
Duration: 01/01/2022 - 31/12/2022

Integración en el Servicio de Enfermedades Infecciosas

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR21/00027
Duration: 26/05/2022 - 25/05/2026

Multicentre Controlled Open Randomized Clinical Trial to assess efficacy and safety of an anti-TB drug combination based on high dose Rifampicin, high dose Moxifloxacin and Linezolid for DS smear positive pulmonary TB during the first 8weeks of treatmen

IP: Adrián Sánchez Montalvá
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Mª Teresa Tórtola Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 187550
Reference: PI20/01378
Duration: 01/01/2021 - 30/06/2025

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.

Related professionals

Jordi Pradell Teigell

Jordi Pradell Teigell

General Surgery
Read more
Mercè Beltran Vilagrasa

Mercè Beltran Vilagrasa

Main researcher
Read more
Marc Ribó Jacobi

Marc Ribó Jacobi

Main researcher
Stroke research
Read more
Maria Amparo Cuxart Fina

Maria Amparo Cuxart Fina

Predoctoral researcher
Maternal and Fetal Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.